The SNOMED CT Drug Model for National Extensions describes the classes of concepts required to extend the international SNOMED CT Medicinal Product Specification, to represent a national drug dictionary in a standardized way. This drug extension concept model describes the real or actual medicinal products (sometimes referred to as 'branded products') available for use in a particular country/territory, and how they can be defined using consistent attributes. The purpose of providing a shared concept model for these drug extensions, is to enable comparison and interoperability between drug concepts in different drug dictionaries, thus enabling use cases such as the sharing of medication lists, contraindication checking, and cross-border pharmacovigillence.
Web browsable version: http://snomed.org/ndem
SNOMED CT Document Library: http://snomed.org/doc
© Copyright 2024 International Health Terminology Standards Development Organisation, all rights reserved. This document is a publication of International Health Terminology Standards Development Organisation, trading as SNOMED International. SNOMED International owns and maintains SNOMED CT®. Any modification of this document (including without limitation the removal or modification of this notice) is prohibited without the express written permission of SNOMED International. This document may be subject to updates. Always use the latest version of this document published by SNOMED International. This can be viewed online and downloaded by following the links on the front page or cover of this document. SNOMED®, SNOMED CT® and IHTSDO® are registered trademarks of International Health Terminology Standards Development Organisation. SNOMED CT® licensing information is available at http://snomed.org/licensing. For more information about SNOMED International and SNOMED International Membership, please refer to http://www.snomed.org or contact us at info@snomed.org. |
Latest PDF Version for Download: | Note This PDF document was generated from the web version on . Any changes made to the web pages since this date will not appear in the PDF. For information about recent changes please see Recent Updates . |
Contents
1. Introduction
2. National Drug Extension Model
- 2.1 Real Medicinal Product (RMP)
- 2.2 Medicinal Product Precisely (MP precisely)
- 2.3 Clinical Drug (CD) with Concentration and Presentation Strengths
- 2.4 Real Clinical Drug (RCD)
- 2.5 Packaged Clinical Drug (PCD)
- 2.6 Real Packaged Clinical Drug (RPCD)
- 2.7 Combination (Real) Packaged Clinical Drugs
- 2.8 Supporting Attributes
Previous Versions
Recent Updates
Feedback
Overview
Content Tools
Apps